Diabetes Models Phenotyping Core The Diabetes Models Phenotyping Core of the Washington University Diabetes Research Center (DRC) has a long-term goal of enhancing diabetes-related research at Washington University through the use of sophisticated services and technologies likely to contribute to discoveries that can be translated to novel treatments for diabetes and its complications. The three objectives of the Core are: 1) To provide phenotyping services to DRC members in order to facilitate NIH-funded diabetes/metabolism-related research and enhance the cost-effectiveness of that research; 2) To train DRC investigators in the maintenance and manipulation of mouse colonies relevant to diabetes and metabolic research; and 3) To develop new research capabilities to enhance the ability of DRC members to perform diabetes and metabolic research. The Core fulfills an important need in the diabetes research community with 52 DRC investigators utilizing services during the past funding period. Over this time frame, the Core provided extensive support that included more than 7,000 biochemical assays of serum, more than 4,400 determinations of mouse body composition, and more than 1,000 indirect calorimetry assessments in mice, to mention the services in greatest demand. Evidence of considerable Core evolution include: elimination of some services, institution of better defined quality control, expanded training to include rigorous approaches to normalizing energy balance and other issues (all in response to criticisms at the time of the last competitive renewal), addition of new instrumentation, upgrades to existing instrumentation, increased physical size of the Core, and improved operational flow. Over this current project period, Diabetes Models Phenotyping Core support helped users contribute a series of important scholarly advances with substantial potential for translation to improved care for people with diabetes.
Diabetes Models Phenotyping Core Diabetes and its related metabolic disorders are serious public health problems that lead to death and disability. Diabetes can be mimicked in animal models, and the study of these models can lead to new treatments with the potential to decrease the suffering from diabetes and its complications. The Diabetes Models Phenotyping Core facility has a goal of supporting scientists who study animal models of diabetes so that novel approaches can be identified to improve the health of people with diabetes.
| Riek, Amy E; Oh, Jisu; Darwech, Isra et al. (2018) Vitamin D3 supplementation decreases a unique circulating monocyte cholesterol pool in patients with type 2 diabetes. J Steroid Biochem Mol Biol 177:187-192 |
| Musselman, Laura Palanker; Fink, Jill L; Maier, Ezekiel J et al. (2018) Seven-Up Is a Novel Regulator of Insulin Signaling. Genetics 208:1643-1656 |
| Bittel, Adam J; Bohnert, Kathryn L; Reeds, Dominic N et al. (2018) Reduced Muscle Strength in Barth Syndrome May Be Improved by Resistance Exercise Training: A Pilot Study. JIMD Rep : |
| Peterson, Linda R; Xanthakis, Vanessa; Duncan, Meredith S et al. (2018) Ceramide Remodeling and Risk of Cardiovascular Events and Mortality. J Am Heart Assoc 7: |
| Ferguson, Daniel; Blenden, Mitchell; Hutson, Irina et al. (2018) Mouse Embryonic Fibroblasts Protect ob/ob Mice From Obesity and Metabolic Complications. Endocrinology 159:3275-3286 |
| Hampton, Kaia K; Anderson, Katie; Frazier, Hilaree et al. (2018) Insulin Receptor Plasma Membrane Levels Increased by the Progesterone Receptor Membrane Component 1. Mol Pharmacol 94:665-673 |
| Warren, Junco S; Tracy, Christopher M; Miller, Mickey R et al. (2018) Histone methyltransferase Smyd1 regulates mitochondrial energetics in the heart. Proc Natl Acad Sci U S A 115:E7871-E7880 |
| Samovski, Dmitri; Dhule, Pallavi; Pietka, Terri et al. (2018) Regulation of Insulin Receptor Pathway and Glucose Metabolism by CD36 Signaling. Diabetes 67:1272-1284 |
| Adams, Melissa T; Gilbert, Jennifer M; Hinojosa Paiz, Jesus et al. (2018) Endocrine cell type sorting and mature architecture in the islets of Langerhans require expression of Roundabout receptors in ? cells. Sci Rep 8:10876 |
| Funk, Steven D; Bayer, Raymond H; Malone, Andrew F et al. (2018) Pathogenicity of a Human Laminin ?2 Mutation Revealed in Models of Alport Syndrome. J Am Soc Nephrol 29:949-960 |
Showing the most recent 10 out of 654 publications
